In laboratories at Washington State University, scientists have uncovered a behavior in common bacteria that reframes our understanding of infection: rather than stumbling into the human bloodstream by chance, organisms like E. coli and Salmonella actively sense and pursue human blood, drawn by the amino acid serine as a source of nourishment. This discovery, which researchers have termed bacterial vampirism, carries particular weight for the roughly one percent of people living with inflammatory bowel disease, for whom such bloodstream infections are a leading cause of death. The finding is n
Plymouth Live
· Jun 17, 2024
· health
· 2 min read
High
Sourcing: Verified
Scientists discover 'vampire bacteria' drawn to human blood, offering hope for new treatments
Bloodstream infections caused by these bacteria are lethal and represent a leading cause of death for inflammatory bowel disease patients.
◉
Science & Space
6405 related articles
South Korean satellite captures SpaceX rocket's lunar impact crater
Google News · 100% match
South Korean Satellite Captures First Images of SpaceX Rocket Crater o…
Google News · 99% match
Euclid's Galactic Preview Supercharges NASA's Roman Telescope Mission
Phys.org · 99% match
SpaceX rocket debris creates lunar crater; NASA studies impact afterma…
Google News · 99% match
South Korean satellite documents SpaceX rocket's unintentional lunar i…
Google News · 99% match
Related Coverage
BBC News · Aug 13
Eclipse dominates UK front pages as papers celebrate 'once in a generation' celestial event
A rare solar eclipse across the UK and Europe captures headlines with dramatic imagery and public celebration, while new…
The New York Times · Aug 13 Total Eclipse Sweeps Across Europe From Iceland to SpainA total solar eclipse crossed Europe from Iceland to Spain, drawing crowds to viewing locations as the moon completely b…
Times of India · Aug 13 Total solar eclipse returns to Spain after 121 years, mesmerizes EuropeA total solar eclipse crossed Spain and Iceland on Wednesday, marking Western Europe's first since 1999 and Spain's firs…
e-flux.com · Aug 13 M-Cult announces 2026–27 artist residencies with open call for Nordic-Baltic creatorsM-Cult opens residency programs in Helsinki with selected international artists exploring urban nature and technology, p…
Bias & Framing
⚖
Article uses sensationalized 'vampire' framing to report legitimate bacterial research, with dramatic language that may overstate findings while presenting genuine scientific discovery.
Bias Direction
center-left
Confidence
MED
Sensationalism through metaphorical language ('vampire bacteria,' 'thirst for human blood,' 'sharks') combined with human-interest angle (IBD patients) to make scientific findings more engaging for general audience.
vampire bacteria
thirst for human blood
potentially deadly
make a beeline
just like sharks
lethal
leading cause of death
Skeptical scientific voices questioning the 'vampirism' terminology or significance
Limitations or caveats of the research not fully explored
Perspective from other research teams in the field
Timeline for potential clinical applications
Cost-benefit analysis of developing treatments based on this discovery
Geopolitical Impact
🌎
Scientific discovery of bacteria attracted to human blood has no direct geopolitical implications; it is a medical research finding with potential therapeutic applications.
Escalation Risk
low
Confidence
HIGH
No shifts in international power, alliances, or influence. This is a biomedical research matter without geopolitical dimensions.
Economic Lens
📈
Discovery of 'vampire bacteria' attracted to human blood could enable new treatments for bloodstream infections, particularly benefiting inflammatory bowel disease patients and reducing infection-related mortality.
Market Signal
bullish
Confidence
MED
Pharmaceutical and biotechnology
Healthcare and medical devices
Diagnostics and laboratory testing
Hospital and clinical services
Patients with inflammatory bowel disease and those at risk of bloodstream infections could benefit from improved treatments, potentially reducing hospitalization rates, treatment costs, and mortality. Broader population may see improved infection management protocols.
Potential FDA fast-track approval pathways for new antimicrobial treatments; increased R&D funding for infectious disease research; updated clinical guidelines for IBD management; possible insurance coverage expansion for novel infection therapies.